In the BioHarmony Drug Report Database

"Preview" Icon

Agalsidase beta

Fabrazyme (agalsidase beta) is an enzyme pharmaceutical. Agalsidase beta was first approved as Fabrazyme on 2001-08-03. It is used to treat fabry disease in the USA. It has been approved in Europe to treat fabry disease.

 

Trade Name

 

Fabrazyme
 

Common Name

 

agalsidase beta
 

ChEMBL ID

 

CHEMBL2108888
 

Indication

 

fabry disease
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Agalsidase beta structure rendering